ARTICLE | Emerging Company Profile
New shot at sepsis
How Critical Pressure’s CPL001 could stabilize septic shock patients
November 17, 2017 10:18 PM UTC
Critical Pressure Ltd. is developing a therapy for septic shock to combat hypotension more effectively than marketed vasopressors, and without their side effects.
Sepsis is a systemic inflammatory response triggered by severe bacterial infection. Over 30% of patients with sepsis develop septic shock, which is characterized by severe hypotension that can lead to tissue damage, multiple organ failure and death. ...
BCIQ Target Profiles